From Quinoxaline, Pyrido[2,3-b]pyrazine and Pyrido[3,4-b]pyrazine to Pyrazino-Fused Carbazoles and Carbolines
作者:Frédéric Lassagne、Timothy Langlais、Elsa Caytan、Emmanuelle Limanton、Ludovic Paquin、Manon Boullard、Coline Courtel、Idriss Curbet、Clément Gédéon、Julien Lebreton、Laurent Picot、Valérie Thiéry、Mohamed Souab、Blandine Baratte、Sandrine Ruchaud、Stéphane Bach、Thierry Roisnel、Florence Mongin
DOI:10.3390/molecules23112961
日期:——
2,3-Diphenylated quinoxaline, pyrido[2,3-b]pyrazine and 8-bromopyrido[3,4-b]pyrazine were halogenated in deprotometalation-trapping reactions using mixed 2,2,6,6-tetramethyl piperidino-based lithium-zinc combinations in tetrahydrofuran. The 2,3-diphenylated 5-iodo- quinoxaline, 8-iodopyrido[2,3-b]pyrazine and 8-bromo-7-iodopyrido[3,4-b]pyrazine thus obtained were subjected to palladium-catalyzed couplings
2,3-二苯基喹喔啉、吡啶并[2,3-b]吡嗪和8-溴吡啶并[3,4-b]吡嗪在脱金属捕集反应中使用混合2,2,6,6-四甲基哌啶基锂被卤化-四氢呋喃中的锌组合。由此获得的2,3-二苯基化5-碘-喹喔啉、8-碘吡啶并[2,3-b]吡嗪和8-溴-7-碘吡啶并[3,4-b]吡嗪与芳基硼酸进行钯催化偶联。酸或苯胺,以及可能的后续环化以提供相应的吡嗪并[2,3-a]咔唑、吡嗪并[2',3':5,6]吡啶并[4,3-b]吲哚和吡嗪并[2',3] ':4,5]吡啶并[2,3-d]吲哚。8-碘吡啶并[2,3-b] 吡嗪经过铜催化与唑类形成CN 键,或直接取代以在8 位引入烷基氨基、苄氨基、肼和芳氧基。8-肼产物转化为芳基腙。对大多数化合物的生物学特性(A2058 黑色素瘤细胞的抗增殖活性和疾病相关激酶抑制作用)进行了评估。